Esperion Therapeutics shares owned by Highbridge Capital Management
Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by Highbridge Capital Management
from 13F filings
Historical chart of Highbridge Capital Management investment in Esperion Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Esperion Therapeutics held by Highbridge Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Esperion Therapeutics by Highbridge Capital Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $663M | 222k | 2990.00 |
2023-09-30 | $249k | 254k | 0.98 |
2023-06-30 | $353k | 254k | 1.39 |
2023-03-31 | $404k | 254k | 1.59 |
2022-12-31 | $1.6M | 254k | 6.23 |
2022-06-30 | $2.7M | 420k | 6.36 |
2022-03-31 | $1.9M | 420k | 4.64 |
2021-12-31 | $1.7M | 346k | 5.00 |
2017-03-31 | $1.1M | 31k | 35.31 |
2016-09-30 | $165k | 12k | 13.78 |
2015-09-30 | $5.6M | 237k | 23.59 |
2015-03-31 | $8.8M | 95k | 92.61 |
More positions owned by Highbridge Capital Management
View all positions for Highbridge Capital Management